Antibody Access Fund (AAF)
A global insurance scheme financed by pharmaceutical companies and wealthy nations to provide subsidized antibody therapies to underserved populations, ensuring equitable access despite growing economic disparities. The AAF uses AI to optimize drug distribution and prevent counterfeiting.